Breast Cancer
IFNG polymorphism in intron 1 associated with increased risk of breast cancer
Published in Cancer Weekly, August 9th, 2005
According to recent research from India, "IFN-gamma is an important Th1 cytokine, which plays a role in immune surveillance and anti-tumor activity. A case-control study involving 54 sporadic breast cancer patients and 144 healthy controls was carried out to explore if the genotype variation of a proposed non-specific enhancer element with a dinucleotide (CA)n repeat in intron 1 has a role in the susceptibility to promote sporadic breast cancer."
"Genotype analysis carried out by single-strand length...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-08-09)
More Articles from Cancer Weekly
- Apoptosis
Environmental UV-A and UV-B threshold doses for treating fibroblasts estimated - Cancer Registries
Cases reported to cancer registries hampered by time delays - Colon Cancer
Early life events related to later risk of colorectal cancer - Cyclophosphamide
Dermal exposure to cyclophosphamide in hospitals discussed - Osteoporosis
Attention focused on emerging oral complication from supportive cancer therapy - Adverse Drug Reactions
Etanercept therapy for rheumatoid arthritis evaluated over 4 years - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
